Clinical trial
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients…
NCT00209573 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00209573 |
|---|---|
| Title | A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy |
| Official title | A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN Injection Versus Midazolam HCl for Sedation in Patients Undergoing Colonoscopy Procedures |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | PPD Development, LP Industry Bio Analytical Research Corporation MDS Pharma Services Coghlan Group (Plasma Sample Supplies) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colonoscopy, Colon Polyps |
| Intervention type | Drug |
| Interventions | fospropofol disodium |
| Enrollment | 270 |
| Start date | Sep 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 7, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: